OverviewChartNewsTraderScreen

DZ Bank Put 2.374 MDG1 21.06.2024/  DE000DQ1YXT6  /

EUWAX
2024-04-23  9:53:47 AM Chg.- Bid10:00:38 PM Ask10:00:38 PM Underlying Strike price Expiration date Option type
0.760EUR - -
Bid Size: -		 -
Ask Size: -		 MEDIGENE AG NA O.N. 2.374 - 2024-06-21 Put
GlobeNewswire 05-07 Medigene to Present at Upcoming Conferences
GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 05-02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 05-02 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 04-26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 04-25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences
GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 2023-12-19 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-11-21 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...
GlobeNewswire 2023-11-21 Medigene amends 2023 financial guidance
GlobeNewswire 2023-11-04 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...
GlobeNewswire 2023-10-26 Medigene Reports Financial Results and Corporate Update for Q3 2023
GlobeNewswire 2023-10-23 Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with...
GlobeNewswire 2023-10-16 Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023
GlobeNewswire 2023-09-27 Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein